- Home
- SPTN vs RLAY Comparison
SPTN vs RLAY Comparison
Compare SPTN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- RLAY
- Stock Information
- Founded
- SPTN 1917
- RLAY 2015
- Country
- SPTN United States
- RLAY United States
- Employees
- SPTN N/A
- RLAY N/A
- Industry
- SPTN Food Distributors
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPTN Consumer Discretionary
- RLAY Health Care
- Exchange
- SPTN Nasdaq
- RLAY Nasdaq
- Market Cap
- SPTN 596.4M
- RLAY 490.3M
- IPO Year
- SPTN N/A
- RLAY 2020
- Fundamental
- Price
- SPTN $17.64
- RLAY $3.18
- Analyst Decision
- SPTN
- RLAY Strong Buy
- Analyst Count
- SPTN 0
- RLAY 11
- Target Price
- SPTN N/A
- RLAY $18.40
- AVG Volume (30 Days)
- SPTN 378.6K
- RLAY 1.5M
- Earning Date
- SPTN 08-14-2025
- RLAY 08-05-2025
- Dividend Yield
- SPTN 4.95%
- RLAY N/A
- EPS Growth
- SPTN N/A
- RLAY N/A
- EPS
- SPTN N/A
- RLAY N/A
- Revenue
- SPTN $9,652,685,000.00
- RLAY $7,679,000.00
- Revenue This Year
- SPTN $6.00
- RLAY $14.31
- Revenue Next Year
- SPTN N/A
- RLAY N/A
- P/E Ratio
- SPTN N/A
- RLAY N/A
- Revenue Growth
- SPTN 0.26
- RLAY N/A
- 52 Week Low
- SPTN $17.30
- RLAY $1.78
- 52 Week High
- SPTN $23.00
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- SPTN 39.17
- RLAY 55.48
- Support Level
- SPTN $17.59
- RLAY $2.98
- Resistance Level
- SPTN $18.27
- RLAY $3.48
- Average True Range (ATR)
- SPTN 0.55
- RLAY 0.25
- MACD
- SPTN -0.09
- RLAY -0.00
- Stochastic Oscillator
- SPTN 4.59
- RLAY 58.45
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).